SPARINGVISION

sparingvision-logo

SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent treatment for retinitis pigmentosa, the most common inherited retinal degeneration. There is currently no treatment to treat all genetic forms of this rare retinal disease that leads to blindness and affects nearly 2 million people worldwide.

#SimilarOrganizations #People #Financial #Event #Website #More

SPARINGVISION

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2016-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.sparingvision.com

Total Employee:
1+

Status:
Active

Contact:
+33(0)1 43 46 20 60

Email Addresses:
[email protected]

Total Funding:
52.74 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome


Similar Organizations

alkermes-logo

Alkermes

Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

owen-smith_image

Owen Smith Non-Executive Director @ SparingVision
Board_member
2020-10-01

benjamin-yerxa_image

Benjamin Yerxa Board Member @ SparingVision
Board_member
2017-12-01

Current Employees Featured

stephane-boissel_image

Stephane Boissel
Stephane Boissel Chairman & CEO @ SparingVision
Chairman & CEO
2020-08-01

mehdi-gasmi_image

Mehdi Gasmi
Mehdi Gasmi COO @ SparingVision
COO

jose-alain-sahel_image

Jose Alain Sahel
Jose Alain Sahel Co-founder @ SparingVision
Co-founder

stanislas-piot_image

Stanislas Piot
Stanislas Piot Chief Financial Officer @ SparingVision
Chief Financial Officer
2020-03-01

thierry-léveillard_image

Thierry Léveillard
Thierry Léveillard Co-founder @ SparingVision
Co-founder

Founder


jose-alain-sahel_image

Jose Alain Sahel

thierry-léveillard_image

Thierry Léveillard

Acquisitions List

Date Company Article Price
2021-04-20 GAMUT Therapeutics GAMUT Therapeutics acquired by SparingVision N/A

Investors List

intellia-therapeutics_image

Intellia Therapeutics

Intellia Therapeutics investment in Corporate Round - SparingVision

jeito-capital_image

Jeito Capital

Jeito Capital investment in Venture Round - SparingVision

foundation-fighting-blindness_image

Foundation Fighting Blindness

Foundation Fighting Blindness investment in Venture Round - SparingVision

4bio-capital-partners_image

4BIO Capital

4BIO Capital investment in Venture Round - SparingVision

ysios-capital_image

Ysios Capital

Ysios Capital investment in Venture Round - SparingVision

upmc-enterprises_image

UPMC Enterprises

UPMC Enterprises investment in Venture Round - SparingVision

bpifrance_image

Bpifrance

Bpifrance investment in Venture Round - SparingVision

Official Site Inspections

http://www.sparingvision.com Semrush global rank: 9.41 M Semrush visits lastest month: 160

  • Host name: 25.26.205.92.host.secureserver.net
  • IP address: 92.205.26.25
  • Location: Germany
  • Latitude: 51.4476
  • Longitude: 7.0122
  • Timezone: Europe/Berlin

Loading ...

More informations about "SparingVision"

Home - SparingVision

Apr 22, 2025 SparingVision Receives FDA Support to Initiate Phase II trial of SPVN06 in Geographic Atrophy Secondary… April 22, 2025 Content Team 2025-04-22T13:00:25+02:00 …See details»

SparingVision - Crunchbase Company Profile & Funding

SparingVision may be growing as indicated by a series of financial and operational developments. The company successfully raised a significant …See details»

People - SparingVision

Dr. Chung was appointed Chief Medical Officer of SparingVision in February 2021. He leads the clinical development and research of our lead programs SPVN06 and SPVN20, and oversees …See details»

SparingVision - Org Chart, Teams, Culture & Jobs - The Org

SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is …See details»

SparingVision - LinkedIn

SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments. Founded to advance over 20 years of world-leading ophthalmic research from its ...See details»

SparingVision's Leadership Team - Team members and org chart

SparingVision's Leadership Team includes Myriam Marussig and 5 others. Team members. Dan Chung. CMO. Florence Lorget. CDSO. Myriam Marussig. COO. Rajiv Gangurde. CTO. …See details»

SparingVision - Contacts, Employees, Board Members, Advisors

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases. ... Experience the new Crunchbase, powered by AI . …See details»

SparingVision 2025 Company Profile: Valuation, …

SparingVision General Information Description. Developer of a medical therapy designed to treat Retinitis Pigmentosa which is part of Inherited Retinal Diseases. The company's offerings include a drug candidate to treat retinitis pigmentosa, …See details»

SparingVision Company Profile - Office Locations, Competitors

SparingVision is a biotechnology company focused on the development of therapies for the treatment of blinding inherited retinal diseases. It offers SPVN06, a gene-independent drug …See details»

News & Media - SparingVision

Apr 22, 2025 SparingVision Announces Presentation of SPVN06 Safety Data at the Macula Society 48th Annual Meeting … February 13, 2025 Read More. Content Team 2025-02-13T13:45:09+01:00. Press Release. SparingVision …See details»

SparingVision Company Profile Funding & Investors - YourStory

SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments. Founded to advance over 20 years of world-leading ophthalmic research from its ...See details»

Dr Daniel C. Chung appointed as Chief Medical Officer of …

Paris, February 04, 2021 – SparingVision (the “Company”), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the appointment of …See details»

A Day in the Life of Biotech Startup SparingVision - servier.com

Dec 19, 2024 SparingVision’s approach: Genotype-Independent Gene Therapy. Gene therapy is an innovative medical strategy that uses DNA as a drug. The goal is to address a mutation (a …See details»

SparingVision - Funding, Financials, Valuation & Investors

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases. New. Resources. Advanced Search. ... How much funding …See details»

Renowned Pioneers in Ophthalmology Join SparingVision’s …

Jan 29, 2021 SparingVision, a genomic medicine company developing vision saving treatments for ocular diseases, today announces the strengthening of its Scientific Advisory Board …See details»

Company: SparingVision

SparingVision is a gene therapy focused company, that develops medicines for the treatment of ocular diseases. The company is currently developing multiple pre-clinical programmes, …See details»

SparingVision Receives Authorization to Launch US Clinical Trial …

Dec 2, 2022 SparingVision, a French company developing therapies for ocular conditions including inherited retinal diseases, has received authorization from the US Food & Drug …See details»

SparingVision Announces Presentation of SPVN06 Safety Data at …

Feb 13, 2025 SparingVision is a genomic medicines company with a mission to translate pioneering science into vision saving treatments. Leveraging its unparalleled understanding of …See details»

Builders Vision | Builders Vision Announces Noelle Laing as New …

3 days ago Chicago, IL – Today, Builders Vision announced that Noelle Laing, CFA, has been promoted to a new role as the sole Chief Investment Officer (CIO) of Builders …See details»

SparingVision Selects Second Target in Strategic Collaboration …

Sep 26, 2023 SparingVision selected a first target in early 2022, with the corresponding product currently in the research phase. Today’s update highlights the identification of a second …See details»

linkstock.net © 2022. All rights reserved